Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05727059 · ClinicalTrials.gov registry record · NA
Magenta Elevate™ EFS in High-Risk PCI Patients
A NA study, sponsored by Magenta Medical.
- Completed
- Registry status
- NA
- Development phase
- 18
- Enrollment target
NCT05727059: Completed NA study, sponsored by Magenta Medical.
NCT05727059 is a NA study that has completed, run by Magenta Medical. The registered enrollment target is 18 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05727059, a NA study, has completed, sponsored by Magenta Medical.
- COMPLETED
- Registry status
- NA
- Development phase
- 18 participants
- Enrollment target
Study Summary
The Elevate™ EFS study is designed to evaluate the safety and feasibility of the Magenta Elevate™ percutaneous Left Ventricular Assist Device (pLVAD) System in patients undergoing non-emergent, high-risk percutaneous coronary interventions.
Primary Outcome
The rate of Elevate™ related Serious Adverse Events
Interventions
- DEVICE The Elevate™ System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2023-05-08 |
| Est. Completion | 2024-01-02 |
| Phase | NA |
What the finished NCT05727059 record still lists
NCT05727059 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 18 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 1 intervention - of which The Elevate™ System is the first listed.
NCT05727059 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05727059 about?
NCT05727059 is a clinical study titled "Magenta Elevate™ EFS in High-Risk PCI Patients". The Elevate™ EFS study is designed to evaluate the safety and feasibility of the Magenta Elevate™ percutaneous Left Ventricular Assist Device (pLVAD) System in patients undergoing non-emergent, high-risk percutaneous coronary interventions.
What is the current status of trial NCT05727059?
This trial is currently completed. It is a NA study. The enrollment target is 18 participants. The study started on 2023-05-08. Estimated completion is 2024-01-02.
What interventions are being tested in trial NCT05727059?
The interventions under investigation include: The Elevate™ System (DEVICE).
Who is sponsoring clinical trial NCT05727059?
This trial is sponsored by Magenta Medical, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05727059's enrollment target sits among peer trials
18 1863rd of 2000 higher than 130 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01245179 · 18 participants · Phase 1
Study of Panobinostat (LBH589) in Patients With Sickle Cell Disease
- NCT01999361 · 18 participants · NA
Prevention of de Novo Allosensitization in Islet Transplant Recipients Following Complete Graft Loss
- NCT02359825 · 18 participants · Phase 1
Nerve Repair Using Hydrophilic Polymers to Promote Immediate Fusion of Severed Axons and Swift Return of Function
- NCT02870244 · 18 participants · Phase 1
Adoptive T Cell Immunotherapy for Advanced Melanoma Using Engineered Lymphocytes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI